MARKET

RCEL

RCEL

Avita Medical Inc
NASDAQ
11.84
+0.26
+2.25%
After Hours: 12.25 +0.41 +3.46% 19:59 09/25 EDT
OPEN
11.64
PREV CLOSE
11.58
HIGH
12.23
LOW
11.56
VOLUME
341.49K
TURNOVER
--
52 WEEK HIGH
12.23
52 WEEK LOW
3.220
MARKET CAP
366.17M
P/E (TTM)
-8.2040
1D
5D
1M
3M
1Y
5Y
1D
Avita Medical’s PermeaDerm Trial Completion: What It Means for RCEL Investors
TipRanks · 3d ago
Avita Medical’s Cohealyx Trial Completion Puts New Focus on Advanced Wound Care
TipRanks · 3d ago
Weekly Report: what happened at RCEL last week (0914-0918)?
Weekly Report · 5d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 09/18 08:30
Small-cap stocks with strong momentum grades and triple-digit YTD gains
Seeking Alpha · 09/17 13:55
Weekly Report: what happened at RCEL last week (0907-0911)?
Weekly Report · 09/14 09:17
Weekly Report: what happened at RCEL last week (0831-0904)?
Weekly Report · 09/07 09:16
6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More
NASDAQ · 09/04 02:47
More
About RCEL
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company solutions are designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management. Its technologies address critical healing needs arising from burns, traumatic injuries, and surgical repairs, through a portfolio and complementary products that support wound bed preparation, definitive closure, and recovery. Its portfolio includes RECELL and two complementary wound care products, PermeaDerm and Cohealyx. Its RECELL technology platform is an autologous cell harvesting technology that enables clinicians to create a suspension of a patient's own skin cells, called Spray-On Skin, at the point of care. Its PermeaDerm is a biosynthetic wound matrix that manufactures, markets, and distributes in the United States, under multi-year agreements with Stedical.

Webull offers AVITA Medical Inc stock information, including NASDAQ: RCEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RCEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RCEL stock methods without spending real money on the virtual paper trading platform.